STOCK TITAN

SurgePays (SURG) Financials

SURG NASDAQ
FY2025 annual
Revenue $57.0M -6.4% YoY
Net Income -$36.1M n/m YoY
EPS (Diluted) -$1.80 n/m YoY
Free Cash Flow -$21.3M n/m YoY
Market Cap $8.4M as of Nov 18, 2026
Price / Sales 0.1x on $67.1M revenue, trailing 12 months to June 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SURG SEC filings page.

SurgePays, Inc. (SURG) reported $57.0M in revenue for fiscal year 2025, down 6.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SURG FY2025

A brief profit period gave way to shrinking sales, cash losses, and liabilities now larger than assets.

FY2025’s gross-margin improvement of 4.9 pp still left cost of revenue above sales, so the better percentage marks a smaller loss rather than healthy unit economics. Net loss was $36.1M while operating cash flow was -$21.3M, showing that reported earnings and cash consumption are aligned in direction, not converted into cash profit.

Balance-sheet leverage has reversed: liabilities were 32.3% of assets in FY2023 but reached 280.9% in FY2025, meaning obligations exceed the recorded asset base. Equity shifted from $28.2M to -$15.3M, while the current ratio fell to 0.4x; the issue is therefore structural solvency pressure, not only near-term liquidity.

Even after SG&A fell 26.9% in FY2025, it still consumed 35.2% of revenue, leaving too little operating scale to absorb the business’s cost base. With capital expenditures of $19K, operating cash outflow was $21.3M; the cash problem is therefore not heavy reinvestment, but losses generated by ongoing operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 20 / 100
Financial Health Score (4 of 6 dimensions) 20/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of SurgePays, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
5

SurgePays, Inc. held $1.7M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $21.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and SurgePays, Inc. scores 5/100 among other emerging companies.

Dilution
50

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. SurgePays, Inc. scores 50/100 on it among other emerging companies.

R&D Intensity
n/a

Not available for SurgePays, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Revenue Progress
11

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. SurgePays, Inc. scores 11/100 on it among other emerging companies.

Burn Trend
n/a

Not available for SurgePays, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Balance Sheet
14

SurgePays, Inc.'s cash, cash equivalents and investments came to $1.7M at the end of fiscal year 2025, against $23.9M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and SurgePays, Inc. scores 14/100 among other emerging companies.

Altman Z-Score Distress
-23.85

SurgePays, Inc. scores -23.85, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $97.0M against total assets of $8.5M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

SurgePays, Inc. passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

SurgePays, Inc. reported a net loss of $36.1M while operations used $21.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

SurgePays, Inc. reported an operating loss of $34.1M against $216K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$16.2M
YoY+40.7%
QoQ+1.4%
5Y CAGR+7.3%
10Y CAGR+32.0%

SurgePays, Inc. generated $16.2M in revenue in Q2 2026. This represents an increase of 40.7% from the same quarter a year earlier. Against the prior quarter it is up 1.4%.

EBITDA
$3.5M
YoYn/m
QoQn/m
5Y CAGRn/m

SurgePays, Inc.'s EBITDA was $3.5M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
$1.3M
YoYn/m
QoQn/m
5Y CAGRn/m
10Y CAGRn/m

SurgePays, Inc. reported $1.3M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
$0.05

SurgePays, Inc. earned $0.05 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Cash & Debt
$2.0M
YoY-55.6%
QoQ-1.9%
5Y CAGR+27.7%
10Y CAGR+40.9%

SurgePays, Inc. held $2.0M in cash against $17.7M in long-term debt as of Q2 2026.

Shares Outstanding
53M

SurgePays, Inc. had 53M shares outstanding in Q2 2026.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
-2.6%
YoY+20.4pp
QoQ+45.5pp
5Y change-14.3pp
10Y change-25.2pp

SurgePays, Inc.'s gross margin was -2.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 20.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 45.5 percentage points.

Operating Margin
21.3%
YoY+80.4pp
QoQ+91.4pp
5Y change+33.7pp

SurgePays, Inc.'s operating margin was 21.3% in Q2 2026, reflecting core business profitability. This is up 80.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 91.4 percentage points.

Net Margin
8.0%
YoY+69.4pp
QoQ+83.3pp
5Y change+9.8pp

SurgePays, Inc.'s net profit margin was 8.0% in Q2 2026, showing the share of revenue converted to profit. This is up 69.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 83.3 percentage points.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

SURG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SURG quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$16.2M+40.7%$16.0M+51.1%$16.2M+68.7%$18.7M+291.6%$11.5M-23.6%$10.6M-66.3%$9.6M-70.3%$4.8M-86.0%
Cost of Revenue$16.6M+17.3%$23.7M+75.2%$18.6M-10.8%$21.3M+68.8%$14.2M-23.5%$13.5M-41.8%$20.8M-16.3%$12.6M-46.8%
Gross Profit-$425Kn/m-$7.7Mn/m-$2.4Mn/m-$2.6Mn/m-$2.7Mn/m-$2.9M-136.0%-$11.2M-250.9%-$7.8M-174.7%
SG&A Expenses$4.6M+11.5%$3.5M-24.5%$6.9M-3.1%$4.4M-32.5%$4.2M-44.1%$4.6M-27.9%$7.1M+8.7%$6.4M+90.3%
Operating Income$3.5Mn/m-$11.2Mn/m-$12.8Mn/m-$7.0Mn/m-$6.8Mn/m-$7.6M-532.7%-$18.4M-2221.5%-$14.3M-301.4%
EBITDA$3.5Mn/m-$11.2Mn/m-$12.8Mn/m-$6.9Mn/m-$6.7Mn/m-$7.5M-511.2%-$18.3M-1763.3%-$14.0M-287.2%
Interest Expense$1.0M+267.5%$882K+638.4%-$608K$425K+276.4%$279K+139.3%$119KN/A$113K
Income TaxN/AN/AN/AN/AN/AN/A-$100KN/A
Net Income$1.3Mn/m-$12.1Mn/m-$13.9Mn/m-$7.5Mn/m-$7.1Mn/m-$7.6M-723.5%-$19.8M-755.8%-$14.3M-301.5%
EPS (Basic)$0.05-$0.51n/m-$0.69n/m-$0.38n/m-$0.36n/m-$0.38-642.9%-$1.02-585.7%-$0.73-246.0%
EPS (Diluted)$0.05-$0.51n/m-$0.69n/m-$0.38n/m-$0.36n/m-$0.38-642.9%-$1.02-636.8%-$0.73-249.0%
Diluted Shares (Avg)26M24M+18.1%N/A20M+0.8%20M+2.4%20M+7.4%N/A20M+35.7%

Not reported in any period shown, so not listed: R&D Expenses.

SURG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SURG quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'24Filing
Total Assets$9.2M-39.3%$9.5M-39.3%$8.5M-64.5%$14.5M-65.1%$15.2M-73.0%$15.7M-77.5%$24.0M-42.8%$41.5M-4.0%
Current Assets$4.9M-49.9%$8.2M-16.7%$7.0M-60.9%$9.2M-72.8%$9.7M-80.1%$9.9M-83.3%$17.9M-46.4%$33.9M-9.0%
Cash & Equivalents$2.0M-55.6%$2.0M-63.1%$1.7M-85.3%$2.5M-81.6%$4.4M-88.5%$5.4M-87.4%$11.8M-19.4%$13.7M+7.2%
Short-Term Investments$0n/m$0n/m$0n/m$0-100.0%$0n/m$0n/m$0n/m$10.1Mn/m
Inventory$254K-89.5%$340K-80.9%$340K-80.9%$1.9M-77.1%$2.4M-71.2%$1.8M-75.7%$1.8M-80.3%$8.4M-42.5%
Accounts Receivable$1.8M-31.8%$5.0M+102.7%$4.0M+34.8%$4.3M+183.4%$2.7M+89.8%$2.5M-69.9%$3.0M-68.5%$1.5M-84.5%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
GoodwillN/AN/AN/A$3.3M-20.8%$3.3M-20.8%$3.3M-20.8%$3.3M+98.0%$4.2M+150.0%
Total Liabilities$30.0M+97.9%$33.4M+323.3%$23.9M+174.5%$20.9M+154.4%$15.2M+49.7%$7.9M-41.2%$8.7M-35.6%$8.2M-57.6%
Current Liabilities$26.2M+200.6%$30.0M+423.4%$18.2M+200.4%$17.7M+225.2%$8.7M+31.8%$5.7M-39.1%$6.1M-52.3%$5.4M-62.5%
Non-Current Liabilities$3.8M-40.7%$3.3M+55.3%$5.7M+115.3%$3.2M+16.4%$6.5M+83.1%$2.1M-46.0%$2.7M+225.0%$2.8M-43.2%
Long-Term Debt$17.7M+84.3%$2.8M-21.7%$15.2M+278.8%$12.0M+171.3%$9.6M+99.5%$3.6M-30.4%$4.0M-20.2%$4.4M-13.5%
Total Equity-$20.7M-17921.7%-$23.8M-403.9%-$15.3M-200.2%-$6.4M-119.2%$116K-99.7%$7.8M-86.0%$15.3M-45.8%$33.2M+39.9%
Retained Earnings-$107.7Mn/m-$109.0Mn/m-$97.0Mn/m-$83.1Mn/m-$75.6Mn/m-$68.6Mn/m-$60.9Mn/m-$41.1Mn/m

SURG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SURG quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$2.6Mn/m-$4.6Mn/m-$3.6Mn/m-$4.6Mn/m-$6.1Mn/m-$7.0M-272.4%-$7.9M-503.4%-$13.3M-264.4%
Depreciation & Amortization$27K-59.6%$27K-68.8%$27K-67.0%$27K-90.5%$66K-5.7%$86K+22.4%$81K-65.2%$282K-26.8%
Stock-Based CompensationN/AN/AN/AN/A$155K-94.8%N/AN/AN/A
Investing Cash FlowN/AN/A$0-100.0%$0$0-$19K$7.6Mn/mN/A
Financing Cash Flow$2.6M-49.4%$5.0Mn/m$3.1Mn/m$2.8Mn/m$5.1Mn/m-$411K-101.7%-$545Kn/m-$874Kn/m

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

SURG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SURG quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin-2.6%+20.4pp-48.2%-20.3pp-14.8%-13.9%-23.1%-0.2pp-27.8%-53.9pp-117.1%-164.2%
Operating Margin21.3%+80.4pp-70.1%+1.6pp-79.0%-37.2%-59.1%+13.0pp-71.7%-77.2pp-191.5%-299.3%
Net Margin8.0%+69.4pp-75.4%-3.2pp-85.6%-40.1%-61.5%+23.8pp-72.2%-76.1pp-206.5%-299.2%
Return on EquityN/AN/AN/AN/A-6099.6%-6071.7pp-97.4%-99.6pp-129.4%-140.1pp-43.0%-73.0pp
Return on Assets14.0%+60.5pp-126.8%-78.1pp-162.8%-80.1pp-51.7%-17.3pp-46.6%-23.7pp-48.7%-50.5pp-82.6%-89.9pp-34.4%-50.8pp
Current Ratio0.19-0.9x0.27-1.4x0.38-2.6x0.52-5.7x1.11-6.3x1.72-4.5x2.95+0.3x6.24+3.7x
Debt-to-EquityN/AN/AN/AN/A82.67+82.6x0.46+0.4x0.26+0.1x0.13-0.1x
Liabilities-to-EquityN/AN/AN/AN/A130.51+130.3x1.01+0.8x0.57+0.1x0.25-0.6x
Asset Turnover1.75+1.0x1.68+1.0x1.90+1.5x1.29+1.2x0.76+0.5x0.68+0.2x0.40-0.4x0.12-0.7x

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$15.3M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.38), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
SurgePays, Inc. SURG FY2025 $57.0M -$36.1M -63.3% $8.4M 20/100
iQSTEL Inc. IQST FY2025 $316.9M -$8.5M -2.7% $7.7M 48/100
uCloudlink Group Inc. UCL FY2025 $81.4M $6.3M 7.7% $7.5M 54/100
iOThree Limited IOTR FY2026 $14.7M -$1.2M -7.9% $9.1M 50/100
FingerMotion, Inc. FNGR FY2026 $24.1M -$7.0M -29.2% $3.7M 28/100
Nixxy, Inc. NIXX FY2025 $97.9M -$15.0M -15.3% $4.0M 23/100

Frequently Asked Questions

SurgePays, Inc. (SURG) reported $57.0M in total revenue for fiscal year 2025. This represents a -6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

SurgePays, Inc. (SURG) revenue declined by 6.4% year-over-year, from $60.9M to $57.0M in fiscal year 2025.

No, SurgePays, Inc. (SURG) reported a net loss of $36.1M in fiscal year 2025, with a net profit margin of -63.3%.

SurgePays, Inc. (SURG) reported diluted earnings per share of -$1.80 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SurgePays, Inc. (SURG) had EBITDA of -$33.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, SurgePays, Inc. (SURG) had $1.7M in cash and equivalents against $15.2M in long-term debt.

SurgePays, Inc. (SURG) had a gross margin of -18.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

SurgePays, Inc. (SURG) had an operating margin of -59.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

SurgePays, Inc. (SURG) had a net profit margin of -63.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

SurgePays, Inc. (SURG) recorded an outflow of $21.3M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

SurgePays, Inc. (SURG) recorded an outflow of $21.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

SurgePays, Inc. (SURG) had $8.5M in total assets as of fiscal year 2025, including both current and long-term assets.

SurgePays, Inc. (SURG) invested $19K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

SurgePays, Inc. (SURG) had 25M shares outstanding as of fiscal year 2025.

SurgePays, Inc. (SURG) had a current ratio of 0.38 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

SurgePays, Inc. (SURG) had a return on assets of -423.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

SurgePays, Inc. (SURG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $8.4M as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

SurgePays, Inc. (SURG) trades at 0.1x sales, its market capitalization divided by $67.1M revenue, trailing 12 months to June 30, 2026. The market capitalization is $8.4M as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, SurgePays, Inc. (SURG) held $1.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $21.3M over that year. Dividing the one by the other, the reported balance equals about 1 month of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

SurgePays, Inc. (SURG) has negative shareholder equity of -$15.3M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

SurgePays, Inc. (SURG) has an Altman Z-Score of -23.85, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

SurgePays, Inc. (SURG) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

SurgePays, Inc. (SURG) reported a net loss of $36.1M while operations used $21.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

SurgePays, Inc. (SURG) reported an operating loss of $34.1M against $216K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

SurgePays, Inc. (SURG) scores 20 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For SurgePays, Inc. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top